World pharmaceutical chemicals demand to increase 6.3% annually through the year 2005. (News Release).
Bulk central nervous system agents demand will benefit from advances in a number of therapies. COX-2 inhibitors for arthritis, acetylcholinesterase inhibitors for Alzheimer's disease, lipase antagonists for obesity and second-generation serotonin reuptake inhibitors for depression will lead growth. Cardiovascular agents will benefit from an increased emphasis on prevention, especially new second-generation tissue plasminogen activators for preventing strokes and heart attacks. Humanized monoclonal antibodies for breast, ovarian and prostate cancer, along with thiazolidinedione antidiabetic agents, will spur rapid growth in demand for bulk hormones and related agents. Reduced dosage protease inhibitors for HIV and AIDS, along with advanced generation macrolides and quinolones, will boost sales of bulk anti-infective agents. Other new pharmaceutical chemicals projected for strong growth in demand include leukotriene blockers for asthma, monoclonal antibodies for transplant rejection, serotonin 5HT3 antagonists for irritable bowel syndrome and vaccines for influenza.
Patent restrictions will continue to deny merchant pharmaceutical chemical companies access to the most rapidly growing drug ingredients. However, many off-patent compounds will generate favorable sales gains based on worldwide trends promoting greater generic drug prescribing as well as on the expansion of preventive medicine and self-treatment activities among consumers. Analgesics, aminopenicillins, cephalosporins, first-generation antihistamines, acid reducers, herbal and related extracts, and calcium and iron minerals are among the pharmaceutical chemicals expected to fare well on the open market.
World Pharmaceutical Chemicals (published 01/2002, 438 pages) is available for $4,500 from The Freedonia Group, Inc., 767 Beta Drive, Cleveland, OH 44143-2326. For further details, please contact Corinne Gangloff by phone 440.684.9600, fax 440.646.0484 or e-mail firstname.lastname@example.org. Information may also be obtained through www.freedoniagroup.com.
WORLD PHARMACEUTICAL CHEMICALS DEMAND (billion US dollars) % Annual Growth Item 1995 2000 2005 00/95 05/00 World Pharmaceutical Chemicals Demand 44.3 61.5 83.5 6.8 6.3 Central Nervous System 9.8 12.6 16.0 5.2 4.9 Cardiovascular 6.2 8.5 11.4 6.5 6.0 Hormones & Related 4.7 7.8 11.8 10.7 8.6 Anti-Infective 5.1 7.3 10.7 7.4 7.9 Respiratory 4.3 5.9 8.0 6.5 6.3 Gastrointestinal 3.8 5.4 7.2 7.3 5.9 Other 10.6 13.9 18.3 5.6 5.7 [c] 2002 by The Freedonia Group, Inc.
|Printer friendly Cite/link Email Feedback|
|Comment:||World pharmaceutical chemicals demand to increase 6.3% annually through the year 2005. (News Release).|
|Publication:||Research Studies - Freedonia Group|
|Article Type:||Brief Article|
|Date:||Jan 28, 2002|
|Previous Article:||US fuel cells demand to expand nearly fourfold to $3.3 billion in the year 2006.|
|Next Article:||World converted flexible packaging to grow 4.6% annually through the year 2005. (News Release).|